Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
11 2021
Historique:
received: 13 01 2021
revised: 12 03 2021
accepted: 12 04 2021
pubmed: 24 4 2021
medline: 23 11 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

To report the relative frequencies of childhood and early onset glaucoma subtypes and their genetic findings in a large single cohort. Retrospective clinical and molecular study. All individuals with childhood glaucoma (diagnosed 0 to <18 years) and early onset glaucoma (diagnosed 18 to <40 years) referred to a national disease registry. We retrospectively reviewed the referrals of all individuals with glaucoma diagnosed at <40 years of age recruited to the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG). Subtypes of glaucoma were determined using the Childhood Glaucoma Research Network (CGRN) classification system. DNA extracted from blood or saliva samples underwent sequencing of genes associated with glaucoma. The phenotype and genotype distribution of glaucoma diagnosed at <40 years of age. A total of 290 individuals (533 eyes) with childhood glaucoma and 370 individuals (686 eyes) with early onset glaucoma were referred to the ANZRAG. Primary glaucoma was the most prevalent condition in both cohorts. In the childhood cohort, 57.6% of individuals (167/290, 303 eyes) had primary congenital glaucoma (PCG), and 19.3% (56/290, 109 eyes) had juvenile open-angle glaucoma. Juvenile open-angle glaucoma constituted 73.2% of the early onset glaucoma cohort (271/370, 513 eyes). Genetic testing in probands resulted in a diagnostic yield of 24.7% (125/506) and a reclassification of glaucoma subtype in 10.4% of probands (13/125). The highest molecular diagnostic rate was achieved in probands with glaucoma associated with nonacquired ocular anomalies (56.5%). Biallelic variants in CYP1B1 (n = 29, 23.2%) and heterozygous variants in MYOC (n = 24, 19.2%) and FOXC1 (n = 21, 16.8%) were most commonly reported among probands with a molecular diagnosis. Biallelic CYP1B1 variants were reported in twice as many female individuals as male individuals with PCG (66.7% vs. 33.3%, P = 0.02). We report on the largest cohort of individuals with childhood and early onset glaucoma from Australasia using the CGRN classification. Primary glaucoma was most prevalent. Genetic diagnoses ascertained in 24.7% of probands supported clinical diagnoses and genetic counseling. International collaborative efforts are required to identify further genes because the majority of individuals still lack a clear molecular diagnosis.

Identifiants

pubmed: 33892047
pii: S0161-6420(21)00288-8
doi: 10.1016/j.ophtha.2021.04.016
pii:
doi:

Substances chimiques

Eye Proteins 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1549-1560

Informations de copyright

Copyright © 2021 American Academy of Ophthalmology. All rights reserved.

Auteurs

Lachlan S W Knight (LSW)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia. Electronic address: Lachlan.WheelhouseKnight@flinders.edu.au.

Jonathan B Ruddle (JB)

Department of Ophthalmology, Royal Children's Hospital, Melbourne, Australia; Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.

Deepa A Taranath (DA)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Ivan Goldberg (I)

Discipline of Ophthalmology, Save Sight Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

James E H Smith (JEH)

Discipline of Ophthalmology, Save Sight Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Department of Ophthalmology, The Children's Hospital at Westmead, Sydney, Australia; Department of Ophthalmology, Macquarie University Hospital, Sydney, Australia.

Glen Gole (G)

University of Queensland Children's Health Queensland Clinical Unit, Queensland Children's Hospital, Brisbane, Australia.

Mark Y Chiang (MY)

Department of Ophthalmology, Queensland Children's Hospital, Brisbane, Australia.

Faren Willett (F)

Department of Ophthalmology, Queensland Children's Hospital, Brisbane, Australia.

Guy D'Mellow (G)

Terrace Eye Centre, Brisbane, Australia.

James Breen (J)

South Australian Genomics Centre, South Australian Health & Medical Research Institute, Adelaide, Australia; Robinson Research Institute, University of Adelaide, Adelaide, Australia; Adelaide Medical School, University of Adelaide, Adelaide, Australia.

Ayub Qassim (A)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Sean Mullany (S)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

James E Elder (JE)

Department of Ophthalmology, Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Andrea L Vincent (AL)

Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand; Eye Department, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand.

Sandra E Staffieri (SE)

Department of Ophthalmology, Royal Children's Hospital, Melbourne, Australia; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.

Lisa S Kearns (LS)

Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.

David A Mackey (DA)

Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Australia; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia; Lions Eye Institute, Centre for Vision Sciences, University of Western Australia, Perth, Australia; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

Susie Luu (S)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Owen M Siggs (OM)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Emmanuelle Souzeau (E)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Jamie E Craig (JE)

Department of Ophthalmology, Flinders University, Flinders Medical Centre, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH